Global Adalimumab Biosimilar Market Status and Outlook 2018-2025

August 2018 | 126 pages | ID: GF9BF3AE7B1EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Market by Type

• Tablet
• Oral Solution

Market by Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Adalimumab Biosimilar Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Tablet
  3.1.2 Oral Solution
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital Pharmacy
  4.1.2 Retail Pharmacy
  4.1.3 Online Pharmacy
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Tablet Production by Region
    6.1.1.2 Oral Solution Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Pharmacy Production by Region
    6.1.2.2 Retail Pharmacy Production by Region
    6.1.2.3 Online Pharmacy Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Tablet Demand by Region
    6.2.1.2 Oral Solution Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Pharmacy Demand by Region
    6.2.2.2 Retail Pharmacy Demand by Region
    6.2.2.3 Online Pharmacy Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 AET BioTech
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Amgen
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Boehringer Ingelheim
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Coherus Biosciences
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Fujifilm Kyowa Kirin Biologics
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 LG Life Sciences/Mochida Pharmaceutical
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Momenta Pharmaceuticals
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Oncobiologics
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Pfizer
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Samsung Bioepsis
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Sandoz
8.12 Zydus Cadila

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Adalimumab Biosimilar Industry Dynamics & Regulations List
Table Global Adalimumab Biosimilar Sales Revenue, Cost and Margin, 2015-2018E
Table Global Adalimumab Biosimilar Market Status by Type 2015-2018E, in USD Million
Table Global Adalimumab Biosimilar Market Status by Application 2015-2018E, in USD Million
Table Global Adalimumab Biosimilar Market Status by Application 2015-2018E, in Volume
Table Global Adalimumab Biosimilar Market by Region 2015-2018E, in USD Million
Table Global Adalimumab Biosimilar Market Share by Region in 2018, in USD Million
Table Global Adalimumab Biosimilar Market by Region 2015-2018E, in Volume
Table Global Adalimumab Biosimilar Market Share by Region in 2018, in Volume
Table Tablet Production Value by Region 2015-2018E, in USD Million
Table Tablet Production Volume by Region 2015-2018E, in Volume
Table Oral Solution Production Value by Region 2015-2018E, in USD Million
Table Oral Solution Production Volume by Region 2015-2018E, in Volume
Table Hospital Pharmacy Production Value by Region 2015-2018E, in USD Million
Table Hospital Pharmacy Production Volume by Region 2015-2018E, in Volume
Table Retail Pharmacy Production Value by Region 2015-2018E, in USD Million
Table Retail Pharmacy Production Volume by Region 2015-2018E, in Volume
Table Online Pharmacy Production Value by Region 2015-2018E, in USD Million
Table Online Pharmacy Production Volume by Region 2015-2018E, in Volume
Table Tablet Market Size by Region 2015-2018E, in USD Million
Table Tablet Market Size by Region 2015-2018E, in Volume
Table Oral Solution Market Size by Region 2015-2018E, in USD Million
Table Oral Solution Market Size by Region 2015-2018E, in Volume
Table Hospital Pharmacy Market Size by Region 2015-2018E, in USD Million
Table Hospital Pharmacy Market Size by Region 2015-2018E, in Volume
Table Retail Pharmacy Market Size by Region 2015-2018E, in USD Million
Table Retail Pharmacy Market Size by Region 2015-2018E, in Volume
Table Online Pharmacy Market Size by Region 2015-2018E, in USD Million
Table Online Pharmacy Market Size by Region 2015-2018E, in Volume
Table GlobalAdalimumab Biosimilar Forecast by Type 2019F-2025F, in USD Million
Table Adalimumab Biosimilar Forecast by Type 2019F-2025F, in Volume
Table Adalimumab Biosimilar Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Adalimumab Biosimilar Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Adalimumab Biosimilar Market Forecast by Region 2019F-2025F, in USD Million
Table Adalimumab Biosimilar Market Forecast by Region 2019F-2025F, in Volume
Table AET BioTech Information
Table Adalimumab Biosimilar Sales, Cost, Margin of AET BioTech
Table Amgen Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Amgen
Table Boehringer Ingelheim Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Boehringer Ingelheim
Table Coherus Biosciences Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Coherus Biosciences
Table Fujifilm Kyowa Kirin Biologics Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Fujifilm Kyowa Kirin Biologics
Table LG Life Sciences/Mochida Pharmaceutical Information
Table Adalimumab Biosimilar Sales, Cost, Margin of LG Life Sciences/Mochida Pharmaceutical
Table Momenta Pharmaceuticals Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Momenta Pharmaceuticals
Table Oncobiologics Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Oncobiologics
Table Pfizer Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Pfizer
Table Samsung Bioepsis Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Samsung Bioepsis
Table Sandoz Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Sandoz
Table Zydus Cadila Information
Table Adalimumab Biosimilar Sales, Cost, Margin of Zydus Cadila
Table Global Adalimumab Biosimilar Sales Revenue by Company 2015-2017, in USD Million
Table Global Adalimumab Biosimilar Sales Volume by Company 2015-2017, in Volume
Table Global Adalimumab Biosimilar Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Adalimumab Biosimilar Picture
Figure Adalimumab Biosimilar Industry Chain Diagram
Figure Global Adalimumab Biosimilar Sales Revenue 2015-2018E, in USD Million
Figure Global Adalimumab Biosimilar Sales Volume 2015-2018E, in Volume
Figure Global Adalimumab Biosimilar Market Status by Type 2015-2018E, in Volume
Figure North America Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure North America Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Europe Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Europe Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure South America Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure South America Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Middle East Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Africa Adalimumab Biosimilar Market Size and Growth 2015-2018E, in USD Million
Figure Africa Adalimumab Biosimilar Market Size and Growth 2015-2018E, in Volume
Figure Global Adalimumab Biosimilar Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Adalimumab Biosimilar Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Adalimumab Biosimilar Sales Price Forecast 2019F-2025F
Figure Global Adalimumab Biosimilar Gross Margin Forecast 2019F-2025F
Figure Global Adalimumab Biosimilar Sales Revenue by Company in 2018, in USD Million
Figure Global Adalimumab Biosimilar Price by Company in 2018
Figure Global Adalimumab Biosimilar Gross Margin by Company in 2018